
Researchers at the University of California, Davis, have identified new compounds with the potential to repair nerve damage caused by multiple sclerosis (MS)…
Researchers at the University of Cambridge’s Gurdon Institute have successfully created lab-grown human embryo-like structures from stem cells, achieving……
In a major development for patients living with hereditary angioedema (HAE), the U.S. Food and Drug Administration (FDA) has approved Garadacimab‑gxii…..
The U.S. Food and Drug Administration (FDA) has approved IBTROZI (Taletrectinib) for the treatment of adult patients with locally advanced or metastatic……
The U.S. Food and Drug Administration (FDA) has approved Enflonsia™ (clesrovimab-cfor) on June 9, 2025, marking a major milestone in the prevention…..